ArticleBMJ open2022

Alpha-2-adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): protocol for a multicentre randomised controlled trial.

Bjørn Erik Neerland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.